How much funding has Actipulse Neuroscience raised?

Actipulse Neuroscience has raised $500K in total funding, most recently a Seed round.

Who are Actipulse Neuroscience's investors?

Actipulse Neuroscience's investors include Y Combinator Continuity Fund.

When was Actipulse Neuroscience founded?

Actipulse Neuroscience was founded in 2017.

Where is Actipulse Neuroscience headquartered?

Actipulse Neuroscience is headquartered in Cambridge, Massachusetts, United States.

What industry is Actipulse Neuroscience in?

Actipulse Neuroscience operates in Healthcare, Medical Devices, Mental Health, Neurotechnology.

How many employees does Actipulse Neuroscience have?

Actipulse Neuroscience has 11-50 employees.

Actipulse Neuroscience

Bringing non-invasive brain stimulation from the hospital to the home

Cambridge, United States · Founded 2017 · $500K raised

YC W22

Headquarters: Cambridge, Massachusetts
Employees: 11–50
Founded: 2017
Website: actipulseneuroscience.com

Total Funding: $500K
Last Round: $500K SeedJan 2022
Rounds: 2

About

Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.

Summary

Actipulse Neuroscience is a Healthcare company based in Cambridge, United States, founded in 2017. It has raised $500K in total across 2 rounds, most recently a $500K Seed round in Jan 2022. Investors include Y Combinator Continuity Fund.